New Zealand markets closed

PFE Jan 2024 22.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
7.150.00 (0.00%)
As of 10:21AM EST. Market open.
Full screen
Previous close7.15
Open7.15
Bid0.00
Ask0.00
Strike22.50
Expiry date2024-01-19
Day's range7.15 - 7.15
Contract rangeN/A
Volume1
Open interestN/A
  • Zacks

    Pfizer (PFE) Declines More Than Market: Some Information for Investors

    In the most recent trading session, Pfizer (PFE) closed at $28.79, indicating a -1.03% shift from the previous trading day.

  • Reuters

    UPDATE 4-AbbVie to buy drug developer Cerevel for $8.7 billion

    AbbVie said on Wednesday it would buy Cerevel Therapeutics, a developer of drugs for neurological conditions, for about $8.7 billion in a bid to replace revenue as its arthritis drug Humira faces a raft of new competition. It marks the second large deal for AbbVie in the past week, coming days after it agreed to buy cancer drug developer ImmunoGen for $10.1 billion in cash, highlighting its appetite to place big bets on promising new medicines. It is paying $45 per share in cash for Cerevel, which is developing drugs for Alzheimer's, Parkinson's, psychosis, epilepsy, and panic disorder.

  • Zacks

    Pfizer (PFE), Arvinas Post Upbeat Data From Breast Cancer Study

    Interim data from an early-stage study shows that treatment with Pfizer (PFE)/Arvinas' (ARVN) breast cancer combination therapy demonstrates encouraging clinical activity in heavily pre-treated patients.